CDMOs anticipate inspection bottlenecks after mass FDA firings

April 14, 2025

Indian CDMO Aragen, for instance, is expecting an FDA inspection of one of its factories in India in the next few quarters, but is unsure if this will be impacted, the company’s chief commercial officer Ashu Tandon said in an interview with Endpoints News. “Until all of this just settles down, it just sort of has a downstream impact on all of us,” he said.